Recent Development of Wnt Signaling Pathway Inhibitors for Cancer Therapeutics

Title
Recent Development of Wnt Signaling Pathway Inhibitors for Cancer Therapeutics
Authors
Keywords
Signaling, Cancer, Canonical, Non-canonical, Clinical trial, FDA approved, Wnt/β-catenin, Wnt/Ca<sup>2+</sup>, Wnt/PCP, Wnt inhibitor, β-Catenin
Journal
Current Oncology Reports
Volume 21, Issue 2, Pages -
Publisher
Springer Nature
Online
2019-02-04
DOI
10.1007/s11912-019-0763-9

Ask authors/readers for more resources

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started